Heart Attack News and Research

RSS

Exposure to heavy wildfire smoke may raise risk of out-of-hospital cardiac arrest

Exposure to heavy smoke during recent California wildfires raised the risk of out-of-hospital cardiac arrests up to 70%, according to new research published today in the Journal of the American Heart Association, the open access journal of the American Heart Association.

15 Apr 2020

Harnessing power of cancer gene could lead to first curative treatment for heart disease

Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell regeneration.

15 Apr 2020

Potential cure for heart disease via cancer gene upregulation

Researchers have found that by switching on a gene that promotes the spread of cancers, they can enhance the regeneration of damaged heart muscle. The study results, published in April 2020 in the journal Nature Communication, could mark the beginning of curative therapy for heart disease.

14 Apr 2020

Breathing heavy wildfire smoke may increase risk of out-of-hospital cardiac arrest

Exposure to heavy smoke during recent California wildfires raised the risk of out-of-hospital cardiac arrests up to 70%.

14 Apr 2020

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Type 2 diabetes affects treatment options for patients who have both coronary artery disease and T2D, according to a new American Heart Association Scientific Statement, published today in the Association's flagship journal Circulation.

13 Apr 2020

Australian study: Many home blood pressure monitors not validated for accuracy

Home monitoring blood pressure devices may not be accurate and could lead to misdiagnoses and inappropriate treatment.

13 Apr 2020

People with type 2 diabetes and heart disease may benefit from newer therapies

Type 2 diabetes (T2D) may affect treatment options for patients who have both coronary artery disease (CAD) and T2D.

13 Apr 2020

New guidance on treating COVID-19 patients with heart attack signs

Much remains unknown about COVID-19, but many studies already have indicated that people with cardiovascular disease are at greater risk of COVID-19.

9 Apr 2020

Using computer software to optimize treatment for diabetic kidney diseases

Diabetic kidney diseases are the main cause of kidney failure in industrialized countries. An international, EU-funded R&D project - which is being headed by the Medical University of Innsbruck, and involves collaboration with the Medical University of Vienna and international partners - is being implemented with the aim of using computer software to provide personalized predictions of the disease's progression and bring about improvements in individuals' responses to treatment.

9 Apr 2020

'Off-the-shelf' artificial cardiac patch improves heart attack recovery in rat and pig models

Researchers from North Carolina State University have developed an "off-the-shelf" artificial cardiac patch that can deliver cardiac cell-derived healing factors directly to the site of heart attack injury. In a rat model of heart attack, the freezable, cell-free patch improved recovery.

8 Apr 2020

Trial assesses tissue plasminogen activator as a treatment for COVID-19-related respiratory failure

A new study published online in the Journal of Trauma and Acute Care Surgery in March 2020 reports that the anticoagulation drug tPA could be a potential aid in managing respiratory failure in patients with COVID-19.

8 Apr 2020

Mysterious heart damage, not just lung troubles, befalling COVID-19 patients

While the focus of the COVID-19 pandemic has been on respiratory problems and securing enough ventilators, doctors on the front lines are grappling with a new medical mystery.

6 Apr 2020

Excess cardiac myosin worsens damage to heart tissue during a heart attack

A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

2 Apr 2020

BU creates COVID-19 US state policy database to track steps taken to slow the pandemic

Researchers and students at the Boston University School of Public Health (BUSPH) have created a COVID-19 US state policy database, tracking steps that each U.S. state has taken to curb the spread of the new coronavirus and when those steps were implemented.

1 Apr 2020

Two newer types of diabetes medications show heart and kidney benefits

Two newer types of medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

New 3D bioprinting technologies to create cardiovascular tissue

Cardiovascular disease is the leading cause of death worldwide, with over 17 million per year according to the World Health Organization.

From IDTechEx Ltd 31 Mar 2020

Ticagrelor therapy, without aspirin, can benefit patients with acute coronary syndrome

Patients with acute coronary syndrome (ACS) who stopped taking aspirin three months after the insertion of a coronary stent and then took the anti-platelet medication ticagrelor alone for nine months had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor for a year.

31 Mar 2020

Clopidogrel added to aspirin and rvaroxaban shows no additional benefit for peripheral artery disease

The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization--a procedure to treat blocked arteries in the leg--had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.

31 Mar 2020

Higher serum EPA levels from prescription fish oil associated with lower cardiovascular events

Higher levels of the omega-3 fatty acid eicosapentaenoic acid (EPA) found in the blood—and not a decrease in triglyceride levels as originally thought—appear to explain the striking reductions in cardiovascular events and deaths seen among people taking 4 grams daily of the prescription fish oil, icosapent ethyl, according to findings from a REDUCE-IT substudy presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology

30 Mar 2020

Clinical trial using genetic testing to guide antiplatelet therapy post-PCI falls short of stated goal

An international clinical trial that used genetic testing to guide which antiplatelet medication was given to patients following percutaneous coronary intervention (PCI) did not meet its stated goal for cutting in half the incidence of serious adverse cardiovascular events, such as heart attack and stroke, in the year following the procedure.

30 Mar 2020

Heart Attack News and Research

Exposure to heavy wildfire smoke may raise risk of out-of-hospital cardiac arrest

Harnessing power of cancer gene could lead to first curative treatment for heart disease

Potential cure for heart disease via cancer gene upregulation

Breathing heavy wildfire smoke may increase risk of out-of-hospital cardiac arrest

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Australian study: Many home blood pressure monitors not validated for accuracy

People with type 2 diabetes and heart disease may benefit from newer therapies

New guidance on treating COVID-19 patients with heart attack signs

Using computer software to optimize treatment for diabetic kidney diseases

'Off-the-shelf' artificial cardiac patch improves heart attack recovery in rat and pig models

Trial assesses tissue plasminogen activator as a treatment for COVID-19-related respiratory failure

Mysterious heart damage, not just lung troubles, befalling COVID-19 patients

Excess cardiac myosin worsens damage to heart tissue during a heart attack

BU creates COVID-19 US state policy database to track steps taken to slow the pandemic

Two newer types of diabetes medications show heart and kidney benefits

New 3D bioprinting technologies to create cardiovascular tissue

Ticagrelor therapy, without aspirin, can benefit patients with acute coronary syndrome

Clopidogrel added to aspirin and rvaroxaban shows no additional benefit for peripheral artery disease

Higher serum EPA levels from prescription fish oil associated with lower cardiovascular events

Clinical trial using genetic testing to guide antiplatelet therapy post-PCI falls short of stated goal

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News